Presuming that PrP evolvability might play a central role in the pathogenesis of all forms of CJD, an evolvability-based therapeutic strategy might, therefore, be engineered against CJD based on the potential mechanisms discussed above. Here, PRNP is linked to Creutzfeldt Jacob disease.